BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 12548250)

  • 1. Which antimicrobial impregnated central venous catheter should we use? Modeling the costs and outcomes of antimicrobial catheter use.
    Marciante KD; Veenstra DL; Lipsky BA; Saint S
    Am J Infect Control; 2003 Feb; 31(1):1-8. PubMed ID: 12548250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group.
    Darouiche RO; Raad II; Heard SO; Thornby JI; Wenker OC; Gabrielli A; Berg J; Khardori N; Hanna H; Hachem R; Harris RL; Mayhall G
    N Engl J Med; 1999 Jan; 340(1):1-8. PubMed ID: 9878638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of Minocycline and Rifampin vs Chlorhexidine and Silver Sulfadiazine-Impregnated Central Venous Catheters in Preventing Central Line-Associated Bloodstream Infection in a High-Volume Academic Intensive Care Unit: A Before and after Trial.
    Bonne S; Mazuski JE; Sona C; Schallom M; Boyle W; Buchman TG; Bochicchio GV; Coopersmith CM; Schuerer DJ
    J Am Coll Surg; 2015 Sep; 221(3):739-47. PubMed ID: 26199017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New choices for central venous catheters: potential financial implications.
    Shorr AF; Humphreys CW; Helman DL
    Chest; 2003 Jul; 124(1):275-84. PubMed ID: 12853534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group.
    Raad I; Darouiche R; Dupuis J; Abi-Said D; Gabrielli A; Hachem R; Wall M; Harris R; Jones J; Buzaid A; Robertson C; Shenaq S; Curling P; Burke T; Ericsson C
    Ann Intern Med; 1997 Aug; 127(4):267-74. PubMed ID: 9265425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial.
    Maki DG; Stolz SM; Wheeler S; Mermel LA
    Ann Intern Med; 1997 Aug; 127(4):257-66. PubMed ID: 9265424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chlorhexidine-silver sulfadiazine- or rifampicin-miconazole-impregnated venous catheters decrease the risk of catheter-related bloodstream infection similarly.
    Lorente L; Lecuona M; Jiménez A; Raja L; Cabrera J; Gonzalez O; Diosdado S; Marca L; Mora ML
    Am J Infect Control; 2016 Jan; 44(1):50-3. PubMed ID: 26412482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chlorhexidine-silver sulfadiazine-impregnated venous catheters are efficient even at subclavian sites without tracheostomy.
    Lorente L; Lecuona M; Jiménez A; Cabrera J; Santacreu R; Lorenzo L; Raja L; Mora ML
    Am J Infect Control; 2016 Dec; 44(12):1526-1529. PubMed ID: 27378009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Types of indwelling urethral catheters for short-term catheterisation in hospitalised adults.
    Lam TB; Omar MI; Fisher E; Gillies K; MacLennan S
    Cochrane Database Syst Rev; 2014 Sep; (9):CD004013. PubMed ID: 25248140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Types of urethral catheters for management of short-term voiding problems in hospitalized adults: a short version Cochrane review.
    Schumm K; Lam TB
    Neurourol Urodyn; 2008; 27(8):738-46. PubMed ID: 18951451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravascular catheters impregnated with antimicrobial agents: a milestone in the prevention of bloodstream infections.
    Raad I; Hanna H
    Support Care Cancer; 1999 Nov; 7(6):386-90. PubMed ID: 10541979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of catheter-associated bloodstream infection after introduction of minocycline and rifampin antimicrobial-coated catheters in a pediatric burn population.
    Weber JM; Sheridan RL; Fagan S; Ryan CM; Pasternack MS; Tompkins RG
    J Burn Care Res; 2012; 33(4):539-43. PubMed ID: 22210071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term silicone central venous catheters impregnated with minocycline and rifampin decrease rates of catheter-related bloodstream infection in cancer patients: a prospective randomized clinical trial.
    Hanna H; Benjamin R; Chatzinikolaou I; Alakech B; Richardson D; Mansfield P; Dvorak T; Munsell MF; Darouiche R; Kantarjian H; Raad I
    J Clin Oncol; 2004 Aug; 22(15):3163-71. PubMed ID: 15284269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of chlorhexidine/silver sulfadiazine-impregnated central venous catheters in an intensive care unit with a low blood stream infection rate after implementation of an educational program: a before-after trial.
    Schuerer DJ; Zack JE; Thomas J; Borecki IB; Sona CS; Schallom ME; Venker M; Nemeth JL; Ward MR; Verjan L; Warren DK; Fraser VJ; Mazuski JE; Boyle WA; Buchman TG; Coopersmith CM
    Surg Infect (Larchmt); 2007 Aug; 8(4):445-54. PubMed ID: 17883361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of Minocycline/Rifampin vs Chlorhexidine/Silver Sulfadiazine-Impregnated Central Venous Catheters.
    Mermel LA
    J Am Coll Surg; 2015 Oct; 221(4):891-2. PubMed ID: 26364070
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative Efficacy of Antimicrobial Central Venous Catheters in Reducing Catheter-Related Bloodstream Infections in Adults: Abridged Cochrane Systematic Review and Network Meta-Analysis.
    Chong HY; Lai NM; Apisarnthanarak A; Chaiyakunapruk N
    Clin Infect Dis; 2017 May; 64(suppl_2):S131-S140. PubMed ID: 28475779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial-impregnated central venous catheters.
    Paterson DL
    N Engl J Med; 1999 Jun; 340(22):1761; author reply 1762. PubMed ID: 10357631
    [No Abstract]   [Full Text] [Related]  

  • 18. Benefits of minocycline and rifampin-impregnated central venous catheters. A prospective, randomized, double-blind, controlled, multicenter trial.
    León C; Ruiz-Santana S; Rello J; de la Torre MV; Vallés J; Alvarez-Lerma F; Sierra R; Saavedra P; Alvarez-Salgado F;
    Intensive Care Med; 2004 Oct; 30(10):1891-9. PubMed ID: 15278273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters.
    Fraenkel D; Rickard C; Thomas P; Faoagali J; George N; Ware R
    Crit Care Med; 2006 Mar; 34(3):668-75. PubMed ID: 16505651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The broad-spectrum activity and efficacy of catheters coated with minocycline and rifampin.
    Raad I; Darouiche R; Hachem R; Mansouri M; Bodey GP
    J Infect Dis; 1996 Feb; 173(2):418-24. PubMed ID: 8568304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.